Cross-species oncogenic signatures of breast cancer in canine mammary tumors
Tae‐Min Kim, In Seok Yang, Byung‐Joon Seung, Sejoon Lee, Dohyun Kim, Yoo-Jin Ha, Mi-Kyoung Seo, Ka-Kyung Kim, Hyun Seok Kim, Jae‐Ho Cheong, Jung‐Hyang Sur, Hojung Nam, Sangwoo Kim
Abstract
Genomic and precision medicine research has afforded notable advances in human cancer treatment, yet applicability to other species remains uncertain. Through whole-exome and transcriptome analyses of 191 spontaneous canine mammary tumors (CMTs) that exhibit the archetypal features of human breast cancers, we found a striking resemblance of genomic characteristics including frequent PIK3CA mutations (43.1%), aberrations of the PI3K-Akt pathway (61.7%), and key genes involved in cancer initiation and progression. We also identified three gene expression-based CMT subtypes, one of which segregated with basal-like human breast cancer subtypes with activated epithelial-to-mesenchymal transition, low claudin expression, and unfavorable disease prognosis. A relative lack of ERBB2 amplification and Her2-enrichment subtype in CMT denoted species-specific molecular mechanisms. Taken together, our results elucidate cross-species oncogenic signatures for a better understanding of universal and context-dependent mechanisms in breast cancer development and provide a basis for precision diagnostics and therapeutics for domestic dogs.